about
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialPrevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysisHigh-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndromeHereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibantSpecial considerations in pregnant systemic sclerosis patients.Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature.Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party.[Haemophagocytic syndrome in pregnancy: a case report].[Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients.Reemergence of Splenectomy for ITP Second-line Treatment?Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.[Renal extramedullary hematopoiesis].Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.Effect of in vitro and in vivo anakinra on cytokines production in Schnitzler syndrome.Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.Relevance of partitioning DLCO to detect pulmonary hypertension in systemic sclerosisNitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.Association between systemic sclerosis and breast cancer: eight new cases and review of the literature.Inflammatory arthritis in patients with myelodysplastic syndromes: a multicenter retrospective study and literature review of 68 cases.A French National Survey on Clotting Disorders in Mastocytosis.Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A French Multicenter Study of 17 Cases and Literature ReviewPulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature.Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study.Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie studyCD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era.Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients.ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.Digestive-tract sarcoidosis: French nationwide case-control study of 25 casesB Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis.Diagnosis and classification of systemic sclerosis.
P50
Q19862843-39BE925E-5DD3-495A-9307-92952662F0EDQ27000819-E56AADD2-D23A-4C60-BA26-44FCE19222BBQ28283828-F6AB8390-5D81-40FD-9E02-05A67907B679Q29248157-BF9CDA6D-4EC8-47AE-832E-45739ED8ECA7Q30244385-1E89B974-3E8B-4703-8035-BCD2527E73A1Q30245016-D5E0C6A2-710F-401E-8C41-39AE03D2277DQ31165345-37F32EDF-87C1-4D6B-91FA-1A6B0094D2BEQ33395411-7D06BF88-CB79-427A-AC35-EE0D3D02DDEEQ33399480-029538C4-2469-4E2D-8BF7-E4ADF6EFDE64Q33426263-39D264C3-FC4C-41CE-907C-F76B098184DBQ33433126-C925CB3C-44BC-4B5B-84C3-F9946A046545Q33436010-0DC71A5B-C71C-44A1-8695-D896764E6FB3Q33673139-89251CF8-D815-4A56-8442-194ACE7D357DQ33757203-7B7F4253-AA24-4F0E-B8A8-CA816EDC6631Q34004145-02AD1598-3506-4ED9-859F-6B5902C257E6Q34219627-54483401-69BC-4108-B122-9047DD58B793Q34268941-06070EA2-EA49-4464-AE48-0DDC24FC99BCQ34447936-CD12451D-ECF9-4997-8775-95D23A80550EQ34635020-D2E9B7B3-71E5-410A-9712-2A049D6D9812Q35008392-42A86CAB-8662-4283-B903-1AE6B1030661Q35035897-CAC1E741-EC24-4F7C-A3B7-026D00310484Q35412114-F4FF06EC-6F86-4EB7-ACCC-0C83BF627537Q35680148-D9B83963-1F5E-4EDE-ABDC-733042A06FA9Q35741844-0D8D2EE7-8C64-490F-A5DE-D2E139EACAEFQ35759176-B47DA579-6497-40C2-9FBA-607451D2FB72Q36084831-7D9AAD67-038D-4876-A919-4C2269FAF11AQ36193594-DC851813-6458-4978-A33E-20EC3FDD20C1Q36195456-BFB798B7-26B4-46AF-935F-CD461CC3CFF1Q36822636-F9BB4A02-4C55-4DBE-B15E-3767F18CE0C3Q36943691-3C366D0D-D23C-4022-A629-4D5856C7361CQ37003609-8C389EE9-CF75-40A3-BB58-B463A67C2A8FQ37038511-ADAEE4C8-4206-447F-93F7-4548F91BD635Q37100627-5025285F-6759-4CB0-9141-D135B7E9DD12Q37216376-F25E3D52-B35C-4A9F-97EB-2D1629C51554Q37345940-F37C1EC0-D366-4359-85C7-99107BFF3C04Q37404896-29510500-9EE7-40C3-B14E-14C1513C167CQ37499442-04FFBD1B-1CDC-44AA-BEDC-ADF6FC2A686FQ37605477-1201F69D-FBC3-43DA-9683-622AB790B14FQ37627201-05475A09-25CF-4F79-967D-B6E01C44CBCBQ37689570-DA952C81-4B82-49DA-A131-5961B8419C62
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
David Launay
@ast
David Launay
@en
David Launay
@es
David Launay
@nl
type
label
David Launay
@ast
David Launay
@en
David Launay
@es
David Launay
@nl
prefLabel
David Launay
@ast
David Launay
@en
David Launay
@es
David Launay
@nl
P214
P1053
H-1674-2016
P106
P21
P214
P2798
P31
P3829
P496
0000-0003-1840-1817
P735
P7859
viaf-192754100